Dana Flavin-König M.D.
Dr. Dana F. Flavin-Koenig has studied medicine and science internationally for the past 30 years. Her extensive background in Chemistry, Biochemistry, Pharmacology, Nutrient Biochemistry and Medicine has allowed her to find new ways of enhancing patients’ responses to all treatments.  Many new treatments were designed specifically for patients who had little improvement from classical pharmacological agents.

Many of her support measures are nutrients and diets that allow patients to remain in remission and live normal symptom-free lives.

Dr. Flavin-Koenig began her extensive research on the Molecular Biology of Cancer in 1979 when she was appointed Science Assistant to the Associate Bureau Director for Toxicology at the Food and Drug Administration in Washington, D.C., USA.

She developed what she calls "Target Therapy", directed to specific negative intracellular changes in tumors and in cancer. This extensive work resulted in the development of nutrient support measures and therapies in many illnesses including Autoimmune Diseases and cancer.